↓ Skip to main content

Cochrane Database of Systematic Reviews

Antiplatelet therapy for acute ischaemic stroke

Overview of attention for article published in this source, July 2008
Altmetric Badge

Mentioned by

1 policy source
1 tweeter


110 Dimensions

Readers on

84 Mendeley
Antiplatelet therapy for acute ischaemic stroke
Published by
John Wiley & Sons, Ltd, July 2008
DOI 10.1002/14651858.cd000029.pub2
Pubmed ID

Sandercock, Peter AG, Counsell, Carl, Gubitz, Gordon J, Tseng, Mei-Chiun


In patients with acute ischaemic stroke, platelets become activated. Antiplatelet therapy might reduce the volume of brain damaged by ischaemia and reduce the risk of early recurrent ischaemic stroke. This might reduce the risk of early death and improve long-term outcome in survivors. However, antiplatelet therapy might also increase the risk of fatal or disabling intracranial haemorrhage.

Twitter Demographics

The data shown below were collected from the profile of 1 tweeter who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 84 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 2 2%
Japan 1 1%
United States 1 1%
Canada 1 1%
Unknown 79 94%

Demographic breakdown

Readers by professional status Count As %
Researcher 18 21%
Student > Ph. D. Student 9 11%
Student > Master 8 10%
Student > Bachelor 8 10%
Student > Postgraduate 7 8%
Other 24 29%
Unknown 10 12%
Readers by discipline Count As %
Medicine and Dentistry 47 56%
Pharmacology, Toxicology and Pharmaceutical Science 6 7%
Neuroscience 6 7%
Agricultural and Biological Sciences 4 5%
Nursing and Health Professions 3 4%
Other 1 1%
Unknown 17 20%